 |
| Cross River State Deputy Governor, Professor Ivara Esu being tested for Hepatitis B and C by Roche Pharmaceuticals |
The Cross River State Government, CRSG, has expressed commitment to partner Roche Pharmaceuticals Limited Nigeria to combat Hepatitis B & C which has been described as a major silence killer disease in the society.
Consequently, a Memorandum of Understanding (MOU) has been signed between the Company and State Government.
Speaking at a Courtesy Call and Signing Ceremony, the Deputy Governor, Professor Ivara Esu expressed worry at the effect of the disease which he noted remains in the body as long as possible after infection without the knowledge of the infected person and would lead to liver, cancer and death.
Professor Esu who expressed happiness for the partnership, urged Roche Nigeria Limited to carry out an extensive sensitization and awareness campaign on the effect of the disease and advised the citizens of the State to go out for screening to know their status and treatment of the disease.
The leader of the team and Country Manager Roche Nigeria Limited, Mr. Hermann Addae said his company is partnering State Governments in the country to help in the treatment of Hepatitis B and C.
He maintained that Roche Pharmaceutical which is a leading company in health care manufacturing is providing an opportunity for Nigerians to diagnose and treat the disease which according to him has affected a great number of people.
Mr. Addae said the company is effectively positioned to bring the scourge of Hepatitis under control in view of its expertise in Health Care related production.
High point of the ceremony was the signing of MOU and testing for Hepatitis on the Deputy Governor and staff of his office.
Report by: Paulyne Eba (Deputy Gov’s Press Unit, Calabar)
